Namita A. Sood

Intensive Care Medicine

2825 J St Ste 400
Sacramento, CA 95816

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Activin Signaling Inhibitors in Pulmonary Hypertension: A State-of-the-Art Review.

Activin Signaling Inhibitors in Pulmonary Hypertension: A State-of-the-Art Review.

Journal: Pulmonary circulation

Published: May 08, 2026

Ralinepag for the treatment of pulmonary arterial hypertension (ADVANCE OUTCOMES): a randomised, double-blind, placebo-controlled phase 3 study.

Ralinepag for the treatment of pulmonary arterial hypertension (ADVANCE OUTCOMES): a randomised, double-blind, placebo-controlled phase 3 study.

Journal: Lancet (London, England)

Published: April 22, 2026

Prognostic Impact of Quantitative CT Disease Extent and Pattern in Fibrotic Hypersensitivity Pneumonitis.

Prognostic Impact of Quantitative CT Disease Extent and Pattern in Fibrotic Hypersensitivity Pneumonitis.

Journal: Annals of the American Thoracic Society

Published: February 25, 2026

Smoking-Related Clinical and Molecular Abnormalities in Idiopathic Pulmonary Fibrosis-Associated Pulmonary Hypertension.

Smoking-Related Clinical and Molecular Abnormalities in Idiopathic Pulmonary Fibrosis-Associated Pulmonary Hypertension.

Journal: Pulmonary circulation

Published: February 18, 2026

Pulmonary Hypertension Training in Pulmonary & Critical Care Medicine Fellowship: A National Survey.

Pulmonary Hypertension Training in Pulmonary & Critical Care Medicine Fellowship: A National Survey.

Journal: ATS scholar

Published: February 01, 2026

Navigating the Complexities of Pulmonary Hypertension Care: Unique Challenges in PAH Management.

Navigating the Complexities of Pulmonary Hypertension Care: Unique Challenges in PAH Management.

Journal: Pulmonary circulation

Published: December 26, 2025

Real-World Outcomes of Inhaled Treprostinil in Pulmonary Hypertension Related to Interstitial Lung Disease: A Multicenter, Retrospective Analysis.

Real-World Outcomes of Inhaled Treprostinil in Pulmonary Hypertension Related to Interstitial Lung Disease: A Multicenter, Retrospective Analysis.

Journal: Journal of cardiovascular development and disease

Published: December 11, 2025

Validity and Prognostic Value of the UCSD Dyspnea Questionnaire in Fibrotic Hypersensitivity Pneumonitis: A Multicenter Prospective Study.

Validity and Prognostic Value of the UCSD Dyspnea Questionnaire in Fibrotic Hypersensitivity Pneumonitis: A Multicenter Prospective Study.

Journal: Annals of the American Thoracic Society

Published: December 10, 2025

Efficacy and Safety of Oral Treprostinil in Patients with Pulmonary Arterial Hypertension on Background Monotherapy or Dual Therapy.

Efficacy and Safety of Oral Treprostinil in Patients with Pulmonary Arterial Hypertension on Background Monotherapy or Dual Therapy.

Journal: Advances in therapy

Published: December 09, 2025

Baseline and Change in Peripheral Blood Transcriptome Enhance Outcome Prediction in Fibrotic Hypersensitivity Pneumonitis: A Prospective Multicenter Cohort Study.

Baseline and Change in Peripheral Blood Transcriptome Enhance Outcome Prediction in Fibrotic Hypersensitivity Pneumonitis: A Prospective Multicenter Cohort Study.

Journal: medRxiv : the preprint server for health sciences

Published: November 26, 2025

Prognostic Impact of Quantitative CT Disease Extent and Pattern in Hypersensitivity Pneumonitis.

Prognostic Impact of Quantitative CT Disease Extent and Pattern in Hypersensitivity Pneumonitis.

Journal: medRxiv : the preprint server for health sciences

Published: November 24, 2025

Managing a Critically Ill Patient With Pulmonary Arterial Hypertension.

Managing a Critically Ill Patient With Pulmonary Arterial Hypertension.

Journal: Chest

Published: November 10, 2025

Showing 1-12 of 39

Last Updated: 09/26/2026